Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMGN

AMGEN Inc

Mar 13 • 04:00PM ET

312.64

Dollar change +0.14
Percentage change 0.04	%

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	41.43	EPS (ttm)	7.55	Insider Own	0.20%	Shs Outstand	536.90M	Perf Week	-1.63%
Market Cap	167.95B	Forward P/E	14.45	EPS next Y	21.64	Insider Trans	-6.94%	Shs Float	536.10M	Perf Month	5.39%
Income	4.09B	PEG	10.49	EPS next Q	4.29	Inst Own	79.19%	Short Float	3.01%	Perf Quarter	12.61%
Sales	33.23B	P/S	5.05	EPS this Y	4.24%	Inst Trans	1.40%	Short Ratio	4.81	Perf Half Y	-4.95%
Book/sh	10.95	P/B	28.56	EPS next Y	4.62%	ROA	4.33%	Short Interest	16.16M	Perf Year	13.54%
Cash/sh	22.29	P/C	14.03	EPS next 5Y	3.95%	ROE	67.55%	52W Range	253.30 - 346.85	Perf YTD	19.95%
Dividend Est.	9.69 (3.10%)	P/FCF	16.16	EPS past 5Y	-10.10%	ROI	6.48%	52W High	-9.86%	Beta	0.58
Dividend TTM	9.13 (2.92%)	Quick Ratio	0.95	Sales past 5Y	7.57%	Gross Margin	66.05%	52W Low	23.43%	ATR (14)	7.81
Dividend Ex-Date	May 16, 2025	Current Ratio	1.26	EPS Y/Y TTM	-39.39%	Oper. Margin	26.26%	RSI (14)	56.84	Volatility	2.92% 2.27%
Employees	28000	Debt/Eq	10.36	Sales Y/Y TTM	18.64%	Profit Margin	12.31%	Recom	2.28	Target Price	314.96
Option/Short	Yes / Yes	LT Debt/Eq	9.74	EPS Q/Q	-18.56%	Payout	119.05%	Rel Volume	0.61	Prev Close	312.50
Sales Surprise	2.31%	EPS Surprise	4.31%	Sales Q/Q	11.16%	Earnings	Feb 04 AMC	Avg Volume	3.36M	Price	312.64
SMA20	1.25%	SMA50	7.88%	SMA200	2.10%	Trades		Volume	2,061,317	Change	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320

Show Previous Ratings

Mar-13-25 01:31PM	Amgens gMG therapy cuts disease symptoms at one-year mark (Clinical Trials Arena)
12:09PM	Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds? (Insider Monkey)
11:36AM	Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year (Benzinga)
09:00AM	UPLIZNA (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS (PR Newswire)
Mar-12-25 10:04AM	Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy (Insider Monkey)
02:17PM	Loading…
Mar-10-25 02:17PM	Stock market sell-off: Why these stocks are in the green amid the pain (Yahoo Finance)
07:30AM	Amgen, Kyowa Kirins rocatinlimab trial for atopic dermatitis meets endpoints (Clinical Trials Arena)
07:30AM	Amgen and Kyowa Kirins rocatinlimab trial for atopic dermatitis meets endpoints (Clinical Trials Arena)
Mar-08-25 10:41AM	3 Magnificent Growth Stocks to Buy in March (Motley Fool)
06:00AM	AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (PR Newswire)
Mar-07-25 06:02AM	The Art of Valuation: Discovering Amgen Inc's Intrinsic Value (GuruFocus.com)
05:03AM	2 Dividend Stocks to Buy for a Lifetime of Passive Income (Motley Fool)
05:00AM	Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup (Quartz)
Mar-06-25 11:31AM	Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue? (Zacks)
05:06AM	Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy (BioPharma Dive)
04:00AM	Loading…
04:00AM	2 Reasons to Watch AMGN and 1 to Stay Cautious (StockStory)
Mar-05-25 04:09PM	Ozempic competitor in the works at Amgen reaches late-stage clinical trials (Quartz)
03:49PM	Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now (Insider Monkey)
03:39PM	Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out (Barrons.com)
01:54PM	Trade Tracker: Joe Terranova sells the XBI, buys Amgen (CNBC TV)
01:31PM	5 Big Biopharmaceutical Stocks That Are Finding Favor (Barrons.com)
01:23PM	Amgen just got one step closer to bringing its Ozempic competitor to market (Quartz)
03:00AM	With patent losses on the horizon, Amgen refocuses its business strategy (Pharma Voice)
Mar-04-25 04:54PM	AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND (PR Newswire)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Mar-03-25 07:44AM	Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP (Clinical Trials Arena)
Mar-01-25 05:30PM	POSITIVE RESULTS FROM TEZSPIRE (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (PR Newswire)
Feb-28-25 05:37PM	Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025 (Insider Monkey)
04:01PM	AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE (PR Newswire)
12:31PM	Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds? (Insider Monkey)
08:45AM	Loading…
08:45AM	This Could Be the Best GLP-1 Stock to Buy in 2025 (Motley Fool)
07:00AM	Drug Stocks Are the New Safe Bet in a Shaky Market (The Wall Street Journal)
06:02AM	Amgen Inc: An Exploration into Its Intrinsic Value (GuruFocus.com)
Feb-27-25 02:27PM	Trade Tracker: Rob Sechan sells McDonald's and Vertex, buys Texas Pacific Land, Amgen and NRG (CNBC TV)
02:27PM	Final Trades: Berkshire Hathaway, Amgen, Prologis and 3M (CNBC TV)
01:57PM	EXCLUSIVE: La La Anthony on Navigating Plaque Psoriasis, Her Partnership With Amgen and Moving Through Life With More Confidence (WWD)
10:10AM	Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 (PR Newswire)
Feb-26-25 04:35AM	Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds? (Insider Monkey)
Feb-25-25 04:53AM	These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys? (Motley Fool)
Feb-24-25 10:00AM	Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025? (Insider Monkey)
01:28AM	Drugmaker Amgen to invest $200 million in India site, CEO says (Reuters)
Feb-22-25 11:12PM	Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts (Insider Monkey)
Feb-21-25 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
Feb-17-25 07:48AM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
02:50AM	Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now (Insider Monkey)
Feb-14-25 04:01PM	AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT (PR Newswire)
09:51AM	Moderna's Q4 loss: Can the pharma giant get to profitability? (Yahoo Finance Video)
Feb-10-25 09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
06:15AM	Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move (Motley Fool)
Feb-09-25 02:30PM	3 Fabulous Dividend Stocks to Buy in February (Motley Fool)
Feb-08-25 05:01PM	Amgen Inc. (AMGN): 'Absurd That This Stock Sells for 14x Earnings' Jim Cramer on Blockbuster Drugs (Insider Monkey)
Feb-07-25 04:01PM	AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE (PR Newswire)
Feb-06-25 04:17PM	Amgen Stock Has Surged. Heres Where Its Headed Next. (Barrons.com)
Feb-05-25 07:36PM	Analyst Report: Amgen Inc. (Morningstar Research) +6.50%
04:30PM	Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs (Investor's Business Daily)
01:09PM	Why Amgen (AMGN) Stock Is Trading Up Today (StockStory)
09:16AM	Q4 2024 Amgen Inc Earnings Call (Thomson Reuters StreetEvents)
07:15AM	These Stocks Are Moving the Most Today: Alphabet, AMD, Apple, Disney, Palantir, Novo Nordisk, FMC, Uber, PDD, and More (Barrons.com)
06:28AM	Amgen obesity drug on hold; Regeneron sets first dividend (BioPharma Dive)
04:51AM	Amgen stock slips on annual outlook; Q4 results top estimates (Investing.com)
02:12AM	Amgen Inc (AMGN) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions (GuruFocus.com)
12:15AM	Amgen (AMGN) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-04-25 07:30PM	Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics (Zacks)
05:35PM	Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug (Bloomberg)
05:27PM	Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold (CNBC TV)
05:10PM	Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:59PM	Amgen Skids On A Surprise Setback For One Of Its Obesity Drugs (Investor's Business Daily)
04:57PM	Amgen, Enphase Energy, Mondelez: After-Hours Earnings (Yahoo Finance Video)
04:18PM	Amgens (NASDAQ:AMGN) Q4 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
04:13PM	Amgen Beat Fourth-Quarter Expectations. So, Why Did Shares Tumble? (Investor's Business Daily)
04:07PM	Amgen: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Amgen profits rise, next MariTide studies start by mid-year (Reuters)
04:01PM	AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS (PR Newswire)
02:10PM	These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025 (Motley Fool)
Feb-02-25 04:05PM	Is Amgen Inc. (AMGN) the Best Cancer Stock to Buy According to Hedge Funds? (Insider Monkey)
Jan-31-25 06:30PM	AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS (PR Newswire)
09:15AM	Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
04:02AM	Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In? (Insider Monkey)
Jan-30-25 09:50AM	Here's Why Amgen (AMGN) is a Strong Momentum Stock (Zacks)
Jan-29-25 04:01PM	EUROPEAN COMMISSION APPROVES BLINCYTO IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE (PR Newswire)
09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
Jan-28-25 05:50PM	Amgen (AMGN) Stock Dips While Market Gains: Key Facts (Zacks)
03:00PM	Drugmakers Show Restraint on Price Increases in New Trump Era (The Wall Street Journal)
10:00AM	Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-27-25 07:17PM	Analyst Report: Amgen Inc. (Morningstar Research)
09:00AM	Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? (Zacks)
04:16AM	Amgen opens new drug substance facility in North Carolina, US (Pharmaceutical Technology)
Jan-24-25 04:17PM	Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms (Investor's Business Daily)
08:38AM	Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results (Investor's Business Daily)
Jan-23-25 06:00PM	Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jan-21-25 05:34AM	Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025? (Motley Fool)
Jan-20-25 07:47AM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
04:38AM	FDA approves Amgens combo therapy for colorectal cancer (Pharmaceutical Technology)
Jan-19-25 06:19PM	Heres Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow (Insider Monkey)
Jan-18-25 07:05PM	Why Amgen Inc. (AMGN) Is One of the Best Cheap Stocks to Buy for 2025? (Insider Monkey)
11:03AM	Why Is Amgen Inc. (AMGN) Among Louis Navelliers Top Long-term Stock Picks? (Insider Monkey)
08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Jan-17-25 05:50PM	Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
09:01AM	FDA APPROVES LUMAKRAS (SOTORASIB) IN COMBINATION WITH VECTIBIX (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER (PR Newswire)
08:11AM	FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients (GuruFocus.com)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM
Grygiel Nancy A.	SVP & CCO	May 03 '24	Sale	313.09	2,117	662,802	9,883	May 03 07:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience